GlassScriptPhysician profile
Michael G Hunt
NPI 1235169798
$1,443.03
in general payments reported to CMS, 2019-2025
17 companies · $105 in 2025
The $105 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22.72 · 2021: $156 · 2022: $494 · 2023: $481 · 2024: $183 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $769.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $230.58 | 2021-2022 | |
| Glaxosmithkline, LLC. | $205.62 | 2020-2023 | Rotarix, Bexsero |
| Abbvie INC. | $195.84 | 2022-2023 | |
| Cranial Technologies, INC | $154.83 | 2021-2024 | Doc Band |
| Ironshore Pharmaceuticals INC. | $135.01 | 2022-2024 | Jornay Pm |
| Corium, LLC | $98.33 | 2021-2023 | Azstarys |
| Merck Sharp & Dohme LLC | $83.64 | 2022-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Seqirus USA INC | $52.87 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Adlon Therapeutics L.P. | $50.40 | 2021 | |
| Novo Nordisk INC | $48.14 | 2023 | Ozempic, Rybelsus |
| Sanofi Pasteur INC. | $47.67 | 2024-2025 | |
| Tris Pharma INC | $36.58 | 2023-2024 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $29.41 | 2021 | |
| Collegium Pharmaceutical, INC. | $21.37 | 2025 | Jornay Pm |
| Neos Therapeutics, LP | $19.11 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.46 | 2023 | |
| Vertical Pharmaceuticals, LLC | $16.17 | 2025 | Relexxii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.